ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation

Mucosal Immunology, Published online: 09 June 2020; doi:10.1038/s41385-020-0307-5ADP/P2Y1 aggravates inflammatory bowel disease through ERK5-mediated NLRP3 inflammasome activation

http://feeds.nature.com/~r/mi/rss/current/~3/kpw0RE8f-ao/s41385-020-0307-5

Source: Mucosal Immunology - June 8, 2020 Category: Allergy & Immunology Authors: Chengfei Zhang Juliang Qin Su Zhang Na Zhang Binhe Tan Stefan Siwko Ying Zhang Qin Wang Jinlian Chen Min Qian Mingyao Liu Bing Du Source Type: research

More News: Allergy & Immunology | Inflammatory Bowel Disease